High-level Expression of Glycoprotein D by a Dominant-negative HSV-1 Virus Augments Its Efficacy as a Vaccine Against HSV-1 Infection

Ítems similars

• Prevention of Genital Herpes Simplex Virus Type 1 and 2 Disease in Mice Immunized with a gD-Expressing Dominant-Negative Recombinant HSV-1
  per: Brans, Richard, et al.
  Publicat: (2009)
• Development of a Glycoprotein D-Expressing Dominant-Negative and Replication-Defective Herpes Simplex Virus 2 (HSV-2) Recombinant Viral Vaccine against HSV-2 Infection in Mice
  per: Akhrameyeva, Natalie V., et al.
  Publicat: (2011)
• Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs
  per: Brans, Richard, et al.
  Publicat: (2010)
• Development of a Regulatable Oncolytic Herpes Simplex Virus Type 1 Recombinant Virus for Tumor Therapy
  per: Yao, Feng, et al.
  Publicat: (2010)
• The Dominant-Negative Herpes Simplex Virus Type 1 (HSV-1) Recombinant CJ83193 Can Serve as an Effective Vaccine against Wild-Type HSV-1 Infection in Mice
  per: Augustinova, Hanka, et al.
  Publicat: (2004)